Live Breaking News & Updates on News Ratings For Acumen Pharmaceuticals Daily

Stay updated with breaking news from News ratings for acumen pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Down 12.0% in May

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 816,000 shares, a decrease of 12.0% from the April 30th total of 926,900 shares. Based on an average trading volume of 297,900 shares, […] ....

Chicago , Illinois , United-states , Dekabank-deutsche-girozentrale , Acumen-pharmaceuticals-trading-down , Nasdaq , Institutional-investors-weigh-in-on-acumen-pharmaceuticals , Sg-americas-securities , Acumen-pharmaceuticals , Chicago-partners-investment-group , Acumen-pharmaceuticals-inc , News-ratings-for-acumen-pharmaceuticals-daily

Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period last year, the firm posted ($0.28) earnings per share. Acumen Pharmaceuticals Stock Performance Shares of ABOS stock […] ....

News-ratings-for-acumen-pharmaceuticals-daily , Earnings-history-for-acumen-pharmaceuticals , Acumen-pharmaceuticals-stock-performance , Acumen-pharmaceuticals-company-profile , Acumen-pharmaceuticals-inc , Acumen-pharmaceuticals , Get-free-report , Acumen-pharmaceuticals-daily ,

Acumen Pharmaceuticals (NASDAQ:ABOS) Posts Earnings Results, Misses Estimates By $0.02 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period in the previous year, the company posted ($0.28) EPS. Acumen Pharmaceuticals Stock Down 2.4 % Acumen Pharmaceuticals stock traded […] ....

Acumen-pharmaceuticals , Acumen-pharmaceuticals-inc , Earnings-history-for-acumen-pharmaceuticals , News-ratings-for-acumen-pharmaceuticals-daily , Acumen-pharmaceuticals-stock-down , Get-free-report , Pharmaceuticals-stock-down , Acumen-pharmaceuticals-daily ,

Acumen Pharmaceuticals' (ABOS) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $15.00 price target on the stock. Acumen Pharmaceuticals Stock Performance ABOS stock traded down $0.04 during trading hours on Wednesday, reaching $3.76. The stock had a trading […] ....

Analyst-recommendations-for-acumen-pharmaceuticals , Franklin-resources-inc , Acumen-pharmaceuticals , News-ratings-for-acumen-pharmaceuticals-daily , Acumen-pharmaceuticals-inc , Knollwood-investment-advisory , Acumen-pharmaceuticals-stock-performance , Free-report , Get-free-report , Springs-capital-management , Capital-management

Acumen Pharmaceuticals (NASDAQ:ABOS) Earns Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $15.00 target price on the stock. Acumen Pharmaceuticals Stock Performance Shares of NASDAQ ABOS traded down $0.04 during trading on Wednesday, hitting $3.76. The company […] ....

Chicago , Illinois , United-states , Acumen-pharmaceuticals , Analyst-recommendations-for-acumen-pharmaceuticals , Jump-financial , Intrepid-financial-planning-group , Citigroup-inc , Acumen-pharmaceuticals-stock-performance , Sg-americas-securities , Chicago-partners-investment-group